Puretech Health plc (PRTC):企業の財務・戦略的SWOT分析

◆英語タイトル:Puretech Health plc (PRTC) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH146999FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年4月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD600 ⇒換算¥76,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥115,200見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Puretech Health Plc (Puretech), formerly PureTech Ventures LLC, is a biopharmaceutical company that develops medicines for diseases caused by dysfunction in the nervous, gastrointestinal, and immune systems. The company develops a microbiome immune system drug-discovery platform and drug candidates for immune-mediated diseases; and products to induce weight loss and enhance glycaemic control through an orally administered capsule. It also develops technology and products for screening, diagnosis, and treatment of neurological disorders such as ADHD, autism, and depression through computer software; non invasive treatment for neuropsychiatric disorders; and combination therapy for schizophrenia. The company offers key experiments and de-risking programs for developing and launching new therapeutics. It markets its products across the US. Puretech is headquartered in Boston, Massachusetts, the US.

Puretech Health Plc Key Recent Developments

Apr 07,2021: PureTech to Present at Two Upcoming Investor Conferences
Apr 07,2021: PureTech Founded Entity Akili Collaborates with Weill Cornell Medicine, NewYork-Presbyterian Hospital and Vanderbilt University Medical Center to Study Digital Therapeutic AKL-T01 as Potential Treatment for Patients with COVID Brain Fog
Mar 26,2021: PureTech Founded Entity Akili Announces the Results of EndeavorRx Clinical Study in Pediatric ADHD Published in Nature Digital Medicine
Mar 03,2021: PureTech to Present at The Barclays Global Healthcare Conference
Feb 25,2021: PureTech announces publication of Glyph platform preclinical proof-of-concept study in journal of controlled release

This comprehensive SWOT profile of Puretech Health Plc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Puretech Health Plc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Puretech Health plc – Key Information
Puretech Health plc – Overview
Puretech Health plc – Key Employees
Puretech Health plc – Key Employee Biographies
Puretech Health plc – Key Operational Heads
Puretech Health plc – Major Products and Services
Puretech Health plc – History
Puretech Health plc – Company Statement
Puretech Health plc – Locations And Subsidiaries
Puretech Health plc
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Puretech Health plc – Business Description
Puretech Health plc – Corporate Strategy
Puretech Health plc – SWOT Analysis
SWOT Analysis – Overview
Puretech Health plc – Strengths
Puretech Health plc – Weaknesses
Puretech Health plc – Opportunities
Puretech Health plc – Threats
Puretech Health plc – Key Competitors

Section 3 – Company Financial Performance Charts

Puretech Health plc – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Puretech Health plc, Key Information
Puretech Health plc, Key Ratios
Puretech Health plc, Share Data
Puretech Health plc, Major Products and Services
Puretech Health plc, History
Puretech Health plc, Key Employees
Puretech Health plc, Key Employee Biographies
Puretech Health plc, Key Operational Heads
Puretech Health plc, Other Locations
Puretech Health plc, Subsidiaries
Puretech Health plc, Key Competitors
Puretech Health plc, SWOT Analysis
Puretech Health plc, Ratios based on current share price
Puretech Health plc, Annual Ratios
Puretech Health plc, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Puretech Health plc (PRTC):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Congenica Ltd:医療機器:M&Aディール及び事業提携情報
    Summary Congenica Ltd (Congenica) is a biotechnology company that offers clinical decision support software and services. The company provides research and experimental development on biotechnology. Its technology SAPIENTIA is used to personalize patient care through accurate diagnoses, drug develop …
  • Astex Pharmaceuticals Inc-製薬・医療分野:企業M&A・提携分析
    Summary Astex Pharmaceuticals Inc (Astex Pharmaceuticals), is a novel drug discovery and development company with a focus on cancer and central nervous system (CNS) diseases. It discovers and develops small molecule treatments. The company’s lead product, Dacogen (indicated for the treatment of myel …
  • Myriad Genetics Inc (MYGN):企業の財務・戦略的SWOT分析
    Myriad Genetics Inc (MYGN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Lung Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Lung Therapeutics Inc (Lung Therapeutics) is a pharmaceutical company that offers orphan drug indications for lung injury and disease. The company provides service to underserved, life-threatening lung condition pursues an innovative treatment. Its pipeline candidates include LTI-01, single …
  • Romaero SA Bucuresti:企業の戦略・SWOT・財務分析
    Romaero SA Bucuresti - Strategy, SWOT and Corporate Finance Report Summary Romaero SA Bucuresti - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Intersnack Group GmbH & Co. KG:企業の戦略・SWOT・財務情報
    Intersnack Group GmbH & Co. KG - Strategy, SWOT and Corporate Finance Report Summary Intersnack Group GmbH & Co. KG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • The AES Corporation:企業の戦略・SWOT・財務情報
    The AES Corporation - Strategy, SWOT and Corporate Finance Report Summary The AES Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Novo Nordisk AS (NOVO B)-医療機器分野:企業M&A・提携分析
    Summary Novo Nordisk A/S (Novo Nordisk), a subsidiary of Novo A/S discovers, develops and manufactures innovative biological medicines. It focuses at developing drugs for treating diabetes and other serious chronic conditions including hemophilia, growth disorders and obesity. The company’s product …
  • Shikoku Electric Power Co Inc (9507):企業の財務・戦略的SWOT分析
    Shikoku Electric Power Co Inc (9507) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Twilio Inc (TWLO):企業の財務・戦略的SWOT分析
    Twilio Inc (TWLO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Nippon Express Co Ltd:企業の戦略・SWOT・財務分析
    Nippon Express Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Nippon Express Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • CoImmune Inc (ARGS):企業の財務・戦略的SWOT分析
    Summary CoImmune Inc(CoImmune) formerly known as Argos Therapeutics Inc, is a biopharmaceutical company that develops and commercializes immunotherapies for the treatment of infectious diseases and cancer. The company develops a pipeline of products based on its proprietary Arcelis technology platfo …
  • Helius Medical Technologies Inc (HSDT):企業の財務・戦略的SWOT分析
    Summary Helius Medical Technologies Inc (HMT) is a medical device company that provides neurological wellness solutions. The company provides development, licensing and acquisition of non-invasive platform technologies for amplifying the brain’s ability to heal itself. It provides development of tec …
  • IBEX Technologies Inc (IBT):企業の財務・戦略的SWOT分析
    Summary IBEX Technologies Inc (IBEX) is a manufacturer and marketer of high-purity proprietary enzymes and recombinant from flavobacterium heparinum. The company provides enzymes such as heparinase I, heparinase II, heparinase III, chondroitinase AC and chondroitinase B. Its assays allow for the stu …
  • RAK Petroleum Plc (RAKP):企業の財務・戦略的SWOT分析
    Summary RAK Petroleum Plc (RAK Petroleum), a subsidiary of RAK Investment Auhtority, is oil and gas company that transports and trades oil, gas and petrochemicals. The company carries out upstream, midstream and downstream activities. It operates its projects in the Middle East and Africa. RAK Petro …
  • Vinnolit GmbH & Co KG:企業の戦略的SWOT分析
    Vinnolit GmbH & Co KG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Animalcare Group Plc (ANCR):企業の財務・戦略的SWOT分析
    Summary Animalcare Group Plc (Animalcare) is a animal healthcare service provider that develops and supplies veterinary medicines and services. The company offers products such as licensed veterinary medicines, companion animal identification and animal welfare products. It offers its product to dog …
  • Senshu Ikeda Holdings Inc:企業の戦略・SWOT・財務情報
    Senshu Ikeda Holdings Inc - Strategy, SWOT and Corporate Finance Report Summary Senshu Ikeda Holdings Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Grupo T-Solar Global SA:電力:M&Aディール及び事業提携情報
    Summary Grupo T-Solar Global SA (T-SOLAR), a subsidiary of Isolux Infrastructure Netherlands BV, is a renewable energy company that generates electricity using photovoltaic technology. The company owns and operates photovoltaic power plants. It offers development, financing and construction, managem …
  • Purepoint Uranium Group Inc (PTU):企業の財務・戦略的SWOT分析
    Purepoint Uranium Group Inc (PTU) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆